| Website | irhythmtech.com |
| Category | BioTech |
| Phone | 415.632.5700 |
| Employees | |
| Founded | 2006 |
| Description | Cardiac Rhythm Monitoring Devices |
| Total | $18.5M |
| Series C, 5/09 Mohr Davidow Ventures Synergy Life Sciences Partner Stanford University | $6.5M |
| Unattributed, 2/07 Synergy Life Sciences Partner Mohr Davidow Ventures | $12M |
iRhythm strives to ensure that cardiac rhythm monitoring becomes more accessible and available to many more patients who may be at risk for an abnormal heart rhythm, or an arrhythmia.
| Website | irhythmtech.com/zio-solution/zio... |
Zio™ is more than a device: it’s an experience. In the cardiac ambulatory monitoring space, it combines novel, patient-centric devices coupled with world-class service from the highly trained staff at the iRhythm National Clinical Center (iNCC).
The development of the Zio™ platform is based on enhancing the overall experience for everyone involved in the monitoring process from start to finish. For physicians, the Zio™ aids in patient diagnosis by combining a simple, sophisticated device with a clear report format. For clinical staff, we offer a hygienic, new device for each patient, and a knowledgeable, responsive service team providing 24 hour, 7 day/week support to help clinical staff members care for their patients. For patients, the devices offer the most inconspicuous, easy-to-wear monitors available, designed to enhance compliance and simplify the monitoring experience, while maximizing diagnostic yields.
